To emphasize the need for standardization, validation, and collaboration in developing psychiatric biomarkers for clinical use as outlined by the American College of Neuropsychopharmacology.
Approach:
Framework Proposal: The ACNP roadmap proposes a framework for moving candidate biomarkers from discovery through validation to regulatory acceptance and routine care.
Potential Approaches: Includes blood assays, genomic markers, electroencephalography, neuroimaging, digital measurements, and combinations of data types.
Analytical Validation: Emphasizes the need for reliable measurement of targets with established performance characteristics before linking results to patient outcomes.
Standardization: Calls for common data elements, reference assays, harmonized protocols, and quality-control procedures to enhance reproducibility.
Regulatory Engagement: Recommends earlier engagement with regulators and independent validation across diverse cohorts.
Key Findings:
Few biomarkers for psychiatric disorders have progressed beyond exploratory research, as noted by the ACNP.
Clinical trials often recruit based on symptoms rather than biological mechanisms, reflecting substantial variation in conditions like depression and schizophrenia.
Combining complementary measurements may provide more informative results than relying on single markers, according to the authors.
Standardization and analytical validation are critical for reliable biomarker development, as emphasized in the ACNP roadmap.
Interpretation:
Near-term applications of biomarkers are expected to focus on clinical trial recruitment, treatment response prediction, drug effect measurement, and safety monitoring, as stated in the source.
Limitations:
Validation alone does not guarantee clinical adoption; tests must also fit into existing laboratory and healthcare workflows, as highlighted by the authors.
Conclusion:
Longer-term goals include developing tools that can distinguish biologically meaningful patient subgroups for precise treatment decisions, as outlined in the ACNP roadmap.